Empirically validated psychosocial therapies for individuals diagnosed with schizophrenia were described in the report of the Schizophrenia Patient Outcomes Research Team (PORT, 2009). The PORT team identified eight psychosocial treatments: assertive community treatment, supported employment, cognitive behavioral therapy, family-based services, token economy, skills training, psychosocial interventions for alcohol and substance use disorders, and psychosocial interventions for weight management. PORT listings of empirically validated psychosocial therapies provide a useful template for the design of effective recovery-oriented mental health care systems. Unfortunately, surveys indicate that PORT listings have not been implemented in clinical settings. Obstacles to the implementation of PORT psychosocial therapy listings and suggestions for changes needed to foster implementation are discussed. Limitations of PORT therapy listings that are based on therapy outcome efficacy studies are discussed, and cross-cultural and course and outcome studies of correlates of recovery are summarized. 1. Introduction Schizophrenia is a group of disorders in which biological, psychological, and sociocultural factors interact synergistically during all phases of the disorder to result in impairments in interpersonal, practical life skills, and vocational functioning. In order to ameliorate the range of symptoms and functional impairments associated with this diagnosis, comprehensive treatment programs are necessary that provide an array of continuing services, including medication management, access to appropriate psychosocial therapies, and assistance with housing, employment, and sources of financial sustenance. Antipsychotic medications can be effective in reducing symptoms and risk of relapse; however, many individuals continue to evidence significant functional and social deficits after acute symptoms have been ameliorated. Growing concerns about the recurring nature of the disorder as well as the severity of functional psychosocial deficits have contributed to an increased emphasis on the importance of empirically validated psychosocial therapies that foster recovery, beyond symptom remission [1]. Recovery-oriented psychosocial treatment programs ideally are designed to provide services designed to help participants learn how to more effectively live with vulnerabilities, reduce interpersonal and social deficits, and promote improved social adaptation and general life functioning [2]. Progress in achieving recovery is fostered by access to comprehensive mental
References
[1]
N. C. Andreasen, W. T. Carpenter, J. M. Kane, R. A. Lasser, S. R. Marder, and D. R. Weinberger, “Remission in schizophrenia: proposed criteria and rationale for consensus,” The American Journal of Psychiatry, vol. 162, no. 3, pp. 441–449, 2005.
[2]
L. Davidson, “PORT through a recovery lens,” Schizophrenia Bulletin, vol. 36, no. 1, pp. 107–108, 2010.
[3]
R. P. Liberman and A. Kopeowicz, “Recovery from schizophrenia: a recovery-based definition,” in Recovery in Mental Illness, R. O. Ralph and P. W. Corrigan, Eds., pp. 101–129, American Psychological Association, Washington, DC, USA, 2005.
[4]
A. F. Lehman, J. Kreyenbuhl, R. W. Buchanan et al., “The schizophrenia patient outcomes research team (PORT): updated treatment recommendations 2003,” Schizophrenia Bulletin, vol. 30, no. 2, pp. 193–217, 2004.
[5]
L. B. Dixon, F. Dickerson, A. S. Bellack et al., “The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements,” Schizophrenia Bulletin, vol. 36, no. 1, pp. 48–70, 2010.
[6]
L. L. Hall, “Half-full but nearly empty: implications of the schizophrenia PORT updated treatment recommendations,” Schizophrenia Bulletin, vol. 30, no. 3, pp. 619–621, 2004.
[7]
E. Latimer, “Economic considerations associated with assertive community treatment and supported employment for people with severe mental illness,” Journal of Psychiatry and Neuroscience, vol. 30, no. 5, pp. 355–359, 2005.
[8]
N. L. DeLuca, L. L. Moser, and G. R. Bond, “Assertive community treatment,” in Clinical Handbook of Schizophrenia, K. T. Mueser and D. V. Jeste, Eds., pp. 329–338, Guilford Press, New York, NY, USA, 2008.
[9]
P. Jeppesen, L. Petersen, A. Thorup et al., “Integrated treatment of first-episode psychosis: effect of treatment on family burden: OPUS trial,” The British Journal of Psychiatry, vol. 187, pp. s85–s90, 2005.
[10]
M. M. Kurtz and K. T. Mueser, “A meta-analysis of controlled research on social skills training for schizophrenia,” Journal of Consulting and Clinical Psychology, vol. 76, no. 3, pp. 491–504, 2008.
[11]
S. M. Essock, K. T. Mueser, R. E. Drake et al., “Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders,” Psychiatric Services, vol. 57, no. 2, pp. 185–196, 2006.
[12]
J. Leff and R. Warner, Social Inclusion of People with Mental Illness, Cambridge University Press, Cambridge, UK, 2006.
[13]
P. B. Gold and G. Waghorn, “Supported employment for people with severe mental illness,” The Lancet, vol. 370, no. 9593, pp. 1108–1109, 2007.
[14]
S. R. McGurk, K. T. Mueser, K. Feldman, R. Wolfe, and A. Pascaris, “Cognitive training for supported employment: 2-3 year outcomes of a randomized controlled trial,” The American Journal of Psychiatry, vol. 164, no. 3, pp. 437–441, 2007.
[15]
J. A. Cook, H. S. Leff, C. R. Blyler et al., “Results of a multisite randomized trial of supported employment interventions for individuals with severe mental illness,” Archives of General Psychiatry, vol. 62, no. 5, pp. 505–512, 2005.
[16]
G. R. Bond and R. E. Drake, “Predictors of competitive employment among patients with schizophrenia,” Current Opinion in Psychiatry, vol. 21, no. 4, pp. 362–369, 2008.
[17]
R. P. Liberman and A. Kopelowicz, “Recovery from schizophrenia: a challenge for the 21st century,” International Review of Psychiatry, vol. 14, no. 4, pp. 245–255, 2002.
[18]
M. M. Kurtz and K. T. Mueser, “A meta-analysis of controlled research on social skills training for schizophrenia,” Journal of Consulting and Clinical Psychology, vol. 76, no. 3, pp. 491–504, 2008.
[19]
D. Turkington, T. Sensky, J. Scott et al., “A randomized controlled trial of cognitive-behavior therapy for persistent symptoms in schizophrenia: a five-year follow-up,” Schizophrenia Research, vol. 98, no. 1-3, pp. 1–7, 2008.
[20]
T. Wykes, C. Steel, B. Everitt, and N. Tarrier, “Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor,” Schizophrenia Bulletin, vol. 34, no. 3, pp. 523–537, 2008.
[21]
G. Zimmermann, J. Favrod, V. H. Trieu, and V. Pomini, “The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis,” Schizophrenia Research, vol. 77, no. 1, pp. 1–9, 2005.
[22]
P. W. Corrigan and R. P. Liberman, “Overview of behavior therapy in psychiatric hospitals,” in Behavior Therapy in Psychiatric Hospitals, P. W. Corrigan and R. P. Liberman, Eds., pp. 1–38, Springer, New York, NY, USA, 1994.
[23]
F. B. Dickerson, W. N. Tenhula, and L. D. Green-Paden, “The token economy for schizophrenia: review of the literature and recommendations for future research,” Schizophrenia Research, vol. 75, no. 2-3, pp. 405–416, 2005.
[24]
S. M. Silverstein, M. Hatashita-Wong, and A. Bloch, “A second chance for people with “treatment-refractory” psychosis,” Psychiatric Services, vol. 53, no. 4, p. 480, 2002.
[25]
D. I. Velligan, R. S. Kern, and J. M. Gold, “Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies,” Schizophrenia Bulletin, vol. 32, no. 3, pp. 474–485, 2006.
[26]
M. Girn, A. Fernndez-Yaez, S. Ma-Alvarenga, A. Molina-Habas, A. Nolasco, and M. Gmez-Beneyto, “Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: a 2-year randomized controlled study,” Psychological Medicine, vol. 40, no. 1, pp. 73–84, 2010.
[27]
M. Pfammatter, U. M. Junghan, and H. D. Brenner, “Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses,” Schizophrenia bulletin, vol. 32, supplement 1, pp. S64–S80, 2006.
[28]
S. Pilling, P. Bebbington, E. Kuipers et al., “Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy,” Psychological Medicine, vol. 32, no. 5, pp. 763–782, 2002.
[29]
P. Jeppesen, L. Petersen, A. Thorup et al., “Integrated treatment of first-episode psychosis: effect of treatment on family burden: OPUS trial,” The British Journal of Psychiatry, vol. 187, pp. s85–s90, 2005.
[30]
B. K. Brent and A. J. Giuliano, “Psychotic-spectrum illness and family-based treatments: a case-based illustration of the underuse of family interventions,” Harvard Review of Psychiatry, vol. 15, no. 4, pp. 161–168, 2007.
[31]
L. F. Mangrum, R. T. Spence, and M. Lopez, “Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders,” Journal of Substance Abuse Treatment, vol. 30, no. 1, pp. 79–84, 2006.
[32]
C. Barrowclough, G. Haddock, N. Tarrier et al., “Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders,” The American Journal of Psychiatry, vol. 158, no. 10, pp. 1706–1713, 2001.
[33]
M. álvarez-Jiménez, S. E. Hetrick, C. González-Blanch, J. F. Gleeson, and P. D. McGorry, “Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials,” The British Journal of Psychiatry, vol. 193, no. 2, pp. 101–107, 2008.
[34]
G. Faulkner, T. Cohn, and G. Remington, “Interventions to reduce weight gain in schizophrenia,” Schizophrenia Bulletin, vol. 33, no. 3, pp. 654–656, 2007.
[35]
G. Faulkner, A. A. Soundy, and K. Lloyd, “Schizophrenia and weight management: a systematic review of interventions to control weight,” Acta Psychiatrica Scandinavica, vol. 108, no. 5, pp. 324–332, 2003.
[36]
J. D. Evans, R. K. Heaton, J. S. Paulsen, B. W. Palmer, T. Patterson, and D. V. Jeste, “The relationship of neuropsychological abilities to specific domains of functional capacity in older schizophrenia patients,” Biological Psychiatry, vol. 53, no. 5, pp. 422–430, 2003.
[37]
M. F. Green, R. S. Kern, and R. K. Heaton, “Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS,” Schizophrenia Research, vol. 72, no. 1, pp. 41–51, 2004.
[38]
W. W. Leung, C. R. Bowie, and P. D. Harvey, “Functional implications of neuropsychological normality and symptom remission in older outpatients diagnosed with schizophrenia: a cross-sectional study,” Journal of the International Neuropsychological Society, vol. 14, no. 3, pp. 479–488, 2008.
[39]
A. Hofer, T. Bodner, A. Kaufmann et al., “Symptomatic remission and neurocognitive functioning in patients with schizophrenia,” Psychological Medicine, vol. 41, no. 10, pp. 2131–2139, 2011.
[40]
J. A. Cook, P. Steigman, S. Pickett et al., “Randomized controlled trial of peer-led recovery education using building recovery of individual dreams and goals through education and support (BRIDGES),” Schizophrenia Research, vol. 136, no. 1–3, pp. 36–42, 2012.
[41]
R. Warner, “Recovery from schizophrenia and the recovery model,” Current Opinion in Psychiatry, vol. 22, no. 4, pp. 374–380, 2009.
[42]
J. Kreyenbuhl, R. W. Buchanan, F. B. Dickerson, and L. B. Dixon, “The schizophrenia patient outcomes research team (PORT): updated treatment recommendations 2009,” Schizophrenia Bulletin, vol. 36, no. 1, pp. 94–103, 2010.
[43]
G. E. Vaillant, “A 10-year followup of remitting schizophrenics,” Schizophrenia Bulletin, vol. 4, no. 1, pp. 78–85, 1978.
[44]
D. Wiersma, F. J. Nienhuis, C. J. Slooff, and R. Giel, “Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort,” Schizophrenia Bulletin, vol. 24, no. 1, pp. 75–85, 1998.
[45]
P. J. Moriarty, D. Lieber, A. Bennett et al., “Gender differences in poor outcome patients with lifelong schizophrenia,” Schizophrenia Bulletin, vol. 27, no. 1, pp. 103–113, 2001.
[46]
C. L. M. Caton, D. S. Hasin, P. E. Shrout et al., “Predictors of psychosis remission in psychotic disorders that co-occur with substance use,” Schizophrenia Bulletin, vol. 32, no. 4, pp. 618–625, 2006.
[47]
M. Oorschot, T. Lataster, V. Thewissen et al., “Symptomatic remission in psychosis and real-life functioning,” The British Journal of Psychiatry, vol. 201, no. 3, pp. 215–220, 2012.
[48]
A. Karow, S. Moritza, M. Lambert, D. Sch？ttle, and D. Naber, “Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia,” European Psychiatry, vol. 27, no. 6, pp. 401–405, 2012.
[49]
R. Rosenheck, D. Leslie, R. Keefe et al., “Barriers to employment for people with schizophrenia,” The American Journal of Psychiatry, vol. 163, no. 3, pp. 411–417, 2006.
[50]
R. Warner, Recovery from Schizophrenia: Psychiatry and Political Economy, Brunner-Routledge, New York, NY, USA, 3rd edition, 2004.
[51]
A. Jablensky, N. Sartorius, G. Ernberg et al., “Schizophrenia manifestations, incidence and course in different cultures. A world health organization ten-country study,” Psychological Medicine Monograph Supplement, vol. 20, pp. 1–97, 1992.
[52]
J. Leff, N. Sartorius, A. Jablensky, A. Korten, and G. Ernberg, “The international pilot study of schizophrenia: five-year follow-up findings,” Psychological Medicine, vol. 22, no. 1, pp. 131–145, 1992.
[53]
N. Satorius, A. Jablensky, G. Ernberg, et al., “Course of schizophrenia in different countires: some results of a WHO international 5-year follow-up study,” in Search for the Causes of Schizophrenia, H. Hafner, W. F. Gattaz, and W. Janzarik, Eds., pp. 107–113, Springer, Berlin, Germany, 1987.
[54]
W. T. Carpenter and J. S. Strauss, “The prediction of outcome in schizophrenia IV: eleven-year follow-up of the Washington IPSS cohort,” Journal of Nervous and Mental Disease, vol. 179, no. 9, pp. 517–525, 1991.
[55]
G. Harrison, K. Hopper, T. Craig et al., “Recovery from psychotic illness: a 15- and 25-year international follow-up study,” The British Journal of Psychiatry, vol. 178, pp. 506–517, 2001.
[56]
H. J. Steadman, F. C. Osher, P. C. Robbins, B. Case, and S. Samuels, “Prevalence of serious mental illness among jail inmates,” Psychiatric Services, vol. 60, no. 6, pp. 761–765, 2009.
[57]
M. R. Munetz and P. A. Griffin, “Use of the sequential intercept model as an approach to decriminalization of people with serious mental illness,” Psychiatric Services, vol. 57, no. 4, pp. 544–549, 2006.
[58]
G. Juckel and P. L. Morosini, “The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia,” Current Opinion in Psychiatry, vol. 21, no. 6, pp. 630–639, 2008.
[59]
J. van Weeghel, S. van de Lindt, C. Slooff, F. van de Kar, M. van Vugt, and D. Wiersma, “A regional assessment of the quality of care for people with schizophrenia in the Netherlands,” Psychiatric Services, vol. 62, no. 7, pp. 789–792, 2011.
[60]
R. G. Frank and S. A. Glied, Better But Not Well: Mental Health Policy in the United States Since 1950, Johns Hopkins University Press, Baltimore, Md, USA, 2006.
[61]
P. C. Panzano, P. Sefrin, C. Chaney-Jones, et al., “The innovation diffusion and adoption research project (IDARP): moving from diffusion of research results to promoting the adoption of evidence-based innovations in the Ohio mental health system,” New Research in Mental Health, vol. 16, pp. 78–89, 2005.
[62]
M. Hogan, “Updated schizophrenia port treatment recommendations: a commentary,” Schizophrenia Bulletin, vol. 36, no. 1, pp. 104–106, 2010.
[63]
G. Thornicroft, A. Alem, R. A. Dos Santos et al., “WPA guidance on steps, obstacles, and mistakes to avoid in the implementation of community mental health care,” World Psychiatry, vol. 9, no. 2, pp. 67–77, 2010.
[64]
H. A. Pincus, “From PORT to policy to patient outcomes: crossing the quality chasm,” Schizophrenia Bulletin, vol. 36, no. 1, pp. 109–111, 2010.
